GlycoNex Incorporation (TPEX:4168)
Taiwan · Delayed Price · Currency is TWD 22.50
+0.20 (0.90%)
Aug 19, 2026, 1:30 PM CST
GlycoNex Incorporation Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 22.21 | 37.86 | 14.7 | 2.54 | 30.09 | 5.48 | |
Revenue Growth | -36.49% | 157.54% | 478.32% | -91.55% | 449.50% | 1113.97% |
Cost of Revenue | 13.07 | 14.35 | 7.38 | 1.55 | 16.12 | 2.01 |
Gross Profit | 9.15 | 23.51 | 7.32 | 1 | 13.97 | 3.46 |
Selling, General & Admin | 54.29 | 50.94 | 48.89 | 50.48 | 55.2 | 53.38 |
Research & Development | 253.15 | 222.38 | 204.55 | 210.38 | 197.41 | 145.01 |
Operating Expenses | 307.43 | 273.32 | 253.44 | 260.86 | 252.92 | 198.39 |
Operating Income | -298.29 | -249.81 | -246.12 | -259.86 | -238.95 | -194.93 |
Interest Expense | -9.07 | -4.49 | -3.63 | -3.63 | -2.75 | - |
Interest & Investment Income | 7.84 | 5.7 | 8.1 | 9.37 | 4.59 | 2.74 |
Currency Exchange Gain (Loss) | 3.61 | 3.61 | 3.46 | -0.55 | -0.48 | -1.07 |
Other Non Operating Income (Expenses) | 25.55 | 10.86 | 8.51 | 17.15 | 17.76 | 20.77 |
EBT Excluding Unusual Items | -270.36 | -234.13 | -229.68 | -237.53 | -219.82 | -172.49 |
Gain (Loss) on Sale of Assets | - | - | - | 73.81 | - | - |
Pretax Income | -270.36 | -234.13 | -229.68 | -163.72 | -219.82 | -172.49 |
Income Tax Expense | 0.04 | 1.09 | 0.02 | 14.65 | - | - |
Net Income | -270.39 | -235.23 | -229.71 | -178.36 | -219.82 | -172.49 |
Net Income to Common | -270.39 | -235.23 | -229.71 | -178.36 | -219.82 | -172.49 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 111 | 109 | 108 | 108 | 99 | 97 |
Shares Outstanding (Diluted) | 111 | 109 | 108 | 108 | 99 | 97 |
Shares Change | 2.20% | 0.55% | 0.35% | 8.42% | 2.49% | 9.25% |
EPS (Basic) | -2.44 | -2.16 | -2.12 | -1.65 | -2.21 | -1.78 |
EPS (Diluted) | -2.44 | -2.16 | -2.12 | -1.65 | -2.21 | -1.78 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -201.22 | -170.86 | -253.24 | -207.34 | -176.24 | -147.7 |
Free Cash Flow Per Share | -1.81 | -1.57 | -2.34 | -1.92 | -1.77 | -1.52 |
Gross Margin | 41.17% | 62.10% | 49.80% | 39.14% | 46.42% | 63.21% |
Operating Margin | -1342.98% | -659.81% | -1674.14% | -10222.82% | -794.24% | -3560.33% |
Profit Margin | -1217.39% | -621.29% | -1562.51% | -7016.60% | -730.67% | -3150.56% |
Free Cash Flow Margin | -905.93% | -451.29% | -1722.63% | -8156.65% | -585.80% | -2697.72% |
EBITDA | -262.33 | -214.39 | -211.74 | -228.69 | -198.99 | -154.8 |
D&A For EBITDA | 35.96 | 35.42 | 34.37 | 31.18 | 39.96 | 40.13 |
EBIT | -298.29 | -249.81 | -246.12 | -259.86 | -238.95 | -194.93 |